Skip to main content
logo
Rekvina Laboratories Limited (BOM:526075)
India flag India · Delayed Price · Currency is INR
25.30
0.00 (0.00%)
At close: Jul 24, 2026

Rekvina Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
12.6512.65----
Revenue Growth
------
Gross Profit
0.840.84----
Operating Income
-2.55-2.55-1.37-0.16-0.04-0.75
Net Income
-2.55-2.55-1.37-0.16-0.01-0.79
Earnings Per Share
-0.42-0.42-0.23-0.03-0.00-0.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.150.150.250.10.10
Total Debt
14.7314.732.470.40.81-
Net Cash (Debt)
-14.57-14.57-2.22-0.3-0.720
Net Cash Growth
------82.48%
Net Cash Per Share
-2.40-2.40-0.37-0.05-0.120.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-5.94-5.94-1.92-0.080.1-0.4
Free Cash Flow
-5.94-5.94-1.92-0.080.1-0.4
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
6.62%6.62%----
Operating Margin
-20.13%-20.13%----
Pretax Margin
-20.13%-20.13%----
Profit Margin
-20.13%-20.13%----

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
12.0517.22----